STEPHEN ROCAMBOLI - 15 Jun 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
15 Jun 2023
Transactions value $
$0
Form type
4
Filing time
16 Jun 2023, 16:06:00 UTC
Previous filing
11 May 2023
Next filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Award $0 +5,150 +63.49% $0 13,261 15 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +21,000 $0 21,000 15 Jun 2023 Common Stock 21,000 $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest in full on the earlier of (i) June 15, 2024 and (ii) the Issuer's next annual meeting of stockholders following June 15, 2023.